Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05453695
PHASE1

Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)

Sponsor: McMaster University

View on ClinicalTrials.gov

Summary

Phase I dose-escalation safety and feasibility of IV DNase I in ICU septic patients.

Official title: Intravenous DNase I for the Treatment of Sepsis: A Phase I Safety and Feasibility Study in ICU Patients

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2023-01-17

Completion Date

2026-09-30

Last Updated

2026-03-03

Healthy Volunteers

No

Interventions

DRUG

Intravenous DNase I

Dose-escalating intravenous infusion of DNase I

Locations (1)

Hamilton Health Sciences

Hamilton, Ontario, Canada